MedPath

Association of Apical Periodontitis With Chronic Kidney Disease

Completed
Conditions
Chronic Kidney Diseases
Periapical Lesions
Interventions
Biological: systemic inflammatory marker, Oral health status, apical periodontitis
Biological: levels of CKD markers, Oral health status, apical periodontitis
Registration Number
NCT05818657
Lead Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Brief Summary

This investigation is aimed to assess the prevalence and severity of apical periodontitis (AP) in different stages of CKD patients and its impact on the systemic (nutritional and inflammatory) markers was compared to healthy individuals.

Detailed Description

105 CKD patients (35 early (EG), 35pre-dialysis (PDG) and 35 hemodialysis (HDG)groups and 105 age and gender matched healthy controls were assessed for prevalence and severity of apical periodontitis and oral disease burden . Inflammatory (hsCRP and ferritin) and nutritional (urea and creatinine) markers were estimated and eGFR was calculated for the study population. Logistic regression was used to determine the possible association between CKD and AP in study population and Linear regression was performed to evaluate the possible association between systemic markers and endodontic burden (EB) in experimental group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • Known patient of CKD Stages 1,2,3,4 & 5 with estimated glomerular filtration rate [eGFR; MDRD] with mature permanent teeth.
  • > 18 years
  • > 8 natural teeth.
  • Complete medical & dental history including panoramic radiographs of maxilla & mandible
Exclusion Criteria
  • Patients having systemic disorders other than CKD (eg HIV, Diabetes mellitus, Coronary heart disease, history of secondary hyperparathyroidism).
  • Pregnancy, lactation & contraceptives.
  • Systemic conditions that contra indicates dental treatment.
  • Use of antibiotics & anti-inflammatory in last 3 months
  • Need for antibiotic prophylaxis.
  • Hepatitis C and B virus.
  • Patients on steroids.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group-B Healthy individualssystemic inflammatory marker, Oral health status, apical periodontitisPrevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis and change in PAI score, eGFR \& Systemic markers will be checked
Group-A CKD patientslevels of CKD markers, Oral health status, apical periodontitisPrevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis and change in PAI score, eGFR \& Systemic markers will be checked
Primary Outcome Measures
NameTimeMethod
serum creatinine1 year

BY BLOOD SAMPLE measured in mg/dL

Blood urea1 year

measured by collecting blood sample in mg/dL

Periapical Index(PAI)1 year

Periodical status will be assessed in periodical radiograph and scoring of periapical index will be done according to size and periphery of peri-apical radiolucency with coding 1 to 5

eGFR1 year

BY BLOOD SAMPLE measured in mL/min/1.73m2

hs-CRP1 year

HIGH SENSITIVE C-reactive protein measured by ELISA kit in mg/L

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PGIDS

🇮🇳

Rohtak, Haryana, India

© Copyright 2025. All Rights Reserved by MedPath